📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 16:03
0 analysed today
FollowTelegram
0
Today
151,433
All-time analysed
43,376
Positive
6,732
Negative
92,513
Neutral
8,744
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Mauria Udyog Q1 PAT drops 27% to ₹4.87 Cr; Auditor flags ₹167 Cr Supreme Court deposit order
Mauria Udyog reported a weak start to FY27, with Q1 revenue declining 18.3% YoY to ₹109.37 Cr and Net Profit falling 26.8% to ₹4.87 Cr. The auditor issued a qualified opinion, highlighting a severe legal risk where the Supreme Court directed the company and its directors to deposit ₹167 Cr related to the Amrapali Group case—a figure nearly 3x the company's net worth of ₹56 Cr. Furthermore, the auditor flagged non-compliance with Ind AS 109 regarding trade receivables and a final SEBI order dated June 30, 2026, which imposed penalties not yet recorded as liabilities.
Confidence: HIGH
What changedThe company reported a significant YoY decline in Q1 profitability and top-line growth, while the auditor reiterated major legal and regulatory liabilities that could impact solvency.
Why it mattersThe potential ₹167 Cr liability is existential for the company, as it far exceeds its net worth of ₹56 Cr and current market capitalization of ₹103 Cr.
Q1 Revenue: ₹109.37 CrQ1 Net Profit: ₹4.87 CrSC Deposit Order: ₹167 CrSC Deposit vs Net Worth: 298.2%Disputed Receivables (Net): ₹63.12 Cr
📅 Short termNegative. The market is likely to react poorly to the earnings decline and the stark auditor warnings regarding legal and regulatory penalties.
📈 Long termHighly uncertain. The company's ability to survive depends on the outcome of the Amrapali-related litigation and its ability to manage a high debt load amidst regulatory restrictions.
⚠ Risk flags
- Legal liability (₹167 Cr SC order)
- Regulatory risk (SEBI final order)
- Auditor qualification (ECL and Fair Value non-compliance)
- High Debt-to-Equity (2.46)
- Significant disputed receivables (₹63.12 Cr)
Key Highlights
Revenue from operations decreased 18.3% YoY to ₹109.37 Cr from ₹133.80 Cr in Jun 2025.
Net Profit for the quarter fell 26.8% YoY to ₹4.87 Cr compared to ₹6.65 Cr in the same period last year.
Auditor highlights a Supreme Court order to deposit ₹167 Cr, which represents ~162% of the company's current market cap.
Disputed and long-outstanding trade receivables worth ₹63.12 Cr (net of provisions) remain classified as non-current.
SEBI issued a final order on June 30, 2026, imposing restrictions/penalties that the company has not yet provided for in its accounts.
👀 What to Watch
Investors should closely monitor the legal resolution of the ₹167 Cr Supreme Court deposit requirement and the specific impact of the SEBI final order. The combination of declining earnings, high debt (D/E 2.46), and severe auditor qualifications makes this a high-risk situation.
5-Year Market Ban for Mauria Udyog and Promoters by SEBI for Price Manipulation
SEBI has issued a final order dated June 30, 2026, restraining Mauria Udyog Ltd and its promoters, Mr. Navneet Kumar Sureka and Mrs. Deepa Sureka, from the securities market for a period of 5 years. The action follows allegations of price and volume manipulation of the company's equity shares in violation of SEBI (PFUTP) Regulations. While the company claims no material impact on operations, the promoters are prohibited from buying, selling, or dealing in securities during this period. The restraint period will be adjusted for time already served under the interim order dated June 19, 2023.
Confidence: HIGH
What changedA final regulatory verdict has been reached, confirming a 5-year market ban for the company and its key promoters following a three-year investigation into market manipulation.
Why it mattersThis is a major corporate governance event that restricts the company's ability to raise equity capital or engage in securities-related transactions for five years, potentially impacting long-term growth and valuation.
Restraint Period: 05 yearsInterim Order Date: June 19, 2023Final Order Date: June 30, 2026Order Receipt Date: July 14, 2026Order Document Length: >300 pages
📅 Short termNegative sentiment is likely as the market reacts to the finality of the SEBI ban and the confirmation of fraudulent trade practice allegations.
📈 Long termThe 5-year ban represents a significant structural hurdle for capital market activities and raises persistent questions regarding promoter integrity and governance.
⚠ Risk flags
- Promoter integrity issues
- Market manipulation findings
- Regulatory non-compliance
- Restriction on capital market access
Key Highlights
5-year ban from accessing the securities market for the company and its promoters
Final order received on July 14, 2026, following an interim order issued on June 19, 2023
Violations cited under SEBI Act, 1992 and PFUTP Regulations, 2003 regarding share price manipulation
Disclosure delayed due to the voluminous nature of the SEBI order, which exceeded 300 pages
Promoters Mr. Navneet Kumar Sureka and Mrs. Deepa Sureka are specifically named in the prohibition
👀 What to Watch
Investors should monitor whether the company or promoters file an appeal with the Securities Appellate Tribunal (SAT). The primary concern is the impact of promoter restrictions on future corporate actions and capital raising capabilities.
5-Year SEBI Market Ban for Mauria Udyog and Promoters over Price Manipulation
SEBI has issued a final order dated June 30, 2026, restraining Mauria Udyog Ltd and its promoters, Navneet Kumar Sureka and Deepa Sureka, from the securities market for 5 years. The order follows investigations into the manipulation of the company's equity share price and volume, violating PFUTP Regulations. The 5-year restraint period will be adjusted for the time already served under the interim order dated June 19, 2023. While the company claims no material impact on operations, the ruling is a significant regulatory action against the leadership.
Confidence: HIGH
What changedA final SEBI order has been passed confirming a 5-year market ban for the company and its promoters, following an interim order issued in 2023.
Why it mattersThis represents a major corporate governance failure and prevents the company from raising equity capital or engaging in market-linked corporate actions for the duration of the ban.
Restraint Period: 05 yearsFinal Order Date: June 30, 2026Interim Order Date: June 19, 2023Receipt of Order: July 14, 2026
📅 Short termNegative sentiment is expected as the finality of the market manipulation charges is confirmed, potentially impacting stock liquidity.
📈 Long termThe company faces a significant governance overhang and is structurally barred from equity-based fundraising or M&A for the remaining ban period.
⚠ Risk flags
- Corporate Governance
- Market Manipulation
- Promoter Ban
Key Highlights
5-year ban from accessing the securities market or dealing in securities for the company and its promoters.
Final Order dated June 30, 2026, received by the company on July 14, 2026.
Restraint period accounts for time already served since the Interim Order of June 19, 2023.
Violations cited under SEBI Act, 1992 and SEBI (Prohibition of Fraudulent and Unfair Trade Practices) Regulations, 2003.
👀 What to Watch
Investors should monitor if the promoters appeal the order at the Securities Appellate Tribunal (SAT) and evaluate the impact of restricted capital market access on future growth.
